Effects of Oxcarbazepine and Levetiracetam on Calcium, Ionized Calcium, and 25-OH Vitamin-D3 Levels in Patients with Epilepsy
|
|
- Tracy Banks
- 5 years ago
- Views:
Transcription
1 Original Article pissn / eissn Clinical Psychopharmacology and Neuroscience 2016;14(1):74-78 Copyrightc 2016, Korean College of Neuropsychopharmacology Effects of Oxcarbazepine and Levetiracetam on Calcium, Ionized Calcium, and 25-OH Vitamin-D3 Levels in Patients with Epilepsy Duygu Aksoy, Betül Tekin Güveli, Pelin Doğan Ak, Hüseyin Sarı, Dilek Ataklı, Baki Arpacı Department of Neurology, Bakirkoy Education and Research Hospital for Psychiatry, Neurology, and Neurosurgery, Istanbul, Turkey Objective: The primary objective of the present study was to further elucidate the effects of oxcarbazepine () and levetiracetam () monotherapies on the bone health status of patients with epilepsy. Methods: This study included 48 patients who attended our epilepsy outpatient clinic, had a diagnosis of epilepsy, and were undergoing either or monotherapy and 42 healthy control subjects. The demographic and clinical features of the patients, including gender, age, onset of disease, daily drug dosage, and duration of disease, were noted. Additionally, the calcium, ionized calcium, and 25-OH vitamin-d3 levels of the participants were prospectively evaluated. Results: The 25-OH vitamin-d3, calcium, and ionized calcium levels of the patients taking were significantly lower than those of the control group. These levels did not significantly differ between the patients taking and the control group, but there was a significant negative relationship between daily drug dose and ionized calcium levels in the patients. Conclusion: In the present study, anti-epileptic drugs altered the calcium, ionized calcium, and 25-OH vitamin-d3 levels of epilepsy patients and resulted in bone loss, abnormal mineralization, and fractures. These findings suggest that the calcium, ionized calcium, and 25-OH vitamin-d3 levels of patients with epilepsy should be regularly assessed. KEY WORDS: Antiepileptic drugs; Levetiracetam; Oxcarbazepine; 25-OH vitamin D3; Bone disease. INTRODUCTION Received: May 19, 2015 / Revised: August 1, 2015 Accepted: August 25, 2015 Address for correspondence: Betül Tekin Güveli, MD Department of Neurology, Bakirkoy Education and Research Hospital for Psychiatry, Neurology, and Neurosurgery, Bakırköy 34147, Istanbul, Turkey Tel: , Fax: betultekin2013@gmail.com Epilepsy is a common neurological disorder associated with recurrent seizures that, in some cases, requires life-long treatment. 1,2) Patients with epilepsy who are taking anti-epileptic drugs (AEDs) have a higher than normal risk of bone loss, abnormal mineralization, and fractures, but the exact pathogenic factors underlying these AEDassociated risks remain unclear. A variety of pathogenic mechanisms have been suggested, including the induction of hepatic enzyme activity with increases in the metabolism of 25-OH vitamin-d3, impaired calcium absorption, the direct effects of old generation AEDs on bone cells, resistance to parathyroid hormones, and an inhibition of calcitonin secretion. 3-6) Several large epidemiological studies found that patients with epilepsy have a two- to sixfold higher risk of fractures than the general population. 7) However, the adverse effects of newer AEDs on bone metabolism are not yet sufficiently known. 8,9) Thus, a determination of the presence of osteoporosis prior to the emergence of clinical signs is important so that measures can be taken to reduce the risk of fractures. It is crucial to evaluate the bone health of epileptic patients and to provide support with calcium and 25-OH vitamin-d3, if needed. 6,10) Thus, the present study analyzed the levels of serum calcium, ionized calcium, and 25-OH vitamin-d3, which are all important for bone metabolism, in patients using oxcarbazepine () or levetiracetam () monotherapies. The present results will aid in the assessment of bone health in patients with epilepsy who are prescribed these drugs as well as in the determination of the precautions necessary to maintain their health. METHODS Participants The present study included 48 patients with epilepsy who had been using or monotherapy for at least 6 months and who volunteered for the study and 42 ageand sex-matched healthy volunteers as a control group. This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. 74
2 Antiepileptic Drugs, Bone Health 75 Table 1. Demographic and clinical characteristics of study participants Drug Gender (n), male/female Age (yr) Duration of disease (yr) Oxcarbazepine 18/ ±10.20 (27-48) 10.64±8.96 (0.5-41) Levetiracetam 8/ ±13.14 (22-49) 8.28±8.61 (2-25) Control group (n=42) 27/ ±7.20 (25-49) - Values are presented as number only or mean±standard deviation (range). The patients were attending the epilepsy outpatient clinic of Bakirkoy Education and Research Hospital for Psychiatry, Neurology and Neurosurgery (Istanbul, Turkey). Participants were excluded if they had a history of an overt medical disorder that could affect bone metabolism, had used medications known to affect bone turnover, had taken calcium or 25-OH vitamin-d3 supplements, had risk factors for osteoporosis (menopause or abnormal menstruation), or were pregnant. Demographic data, including gender, age, type of epilepsy, type of seizure, duration of disease, duration of treatment, and drug dosage, were obtained. Venous blood samples were taken between AM 08:30 and 09:00 and then analyzed for calcium, ionized calcium, and 25-OH vitamin-d3 levels. The optimal serum levels of calcium, ionized calcium, and 25-OH vitamin-d3 were considered to be mg/dl, mg/dl, and ng/ml, respectively. Statistical Analysis All statistical analyses were performed using Number Cruncher Statistical System (NCSS) 2007 (NCSS LLC, Kaysville, UT, USA), Power Analysis and Sample Size (PASS; NCSS LLC), and Statistical Software 2008 (NCSS LLC). Student s t-tests were used to compare the quantitative data between two groups, a one-way analysis of variance (ANOVA) was used to compare the data of three or more groups, and Tukey s honest significant difference tests were used to determine differences among the groups. Mann-Whitney U-tests were used to compare two groups and Kruskal-Wallis tests were used to compare three or more groups in cases of groups that were not normally distributed. Mann-Whitney U-tests were also used to determine discrepancies among the groups. Pearson s chi-square tests were used to compare qualitative data, and Pearson s and Spearman s correlation analyses were used to analyze relationships among the parameters. p values <0.01 and <0.05 were considered to indicate statistical significance. RESULTS The present study included 48 patients with epilepsy Table 2. Calcium, ionized calcium, and 25-OH vitamin-d3 levels in patients Gender Control group (n=42) Calcium F 8.85± ± ±0.33 M 9.12± ± ±0.42 p* Ionized calcium F 4.21± ± ±0.18 M 4.35± ± ±0.25 p* OH vitamin-d3 F 5.87± ± ±10.32 M 10.12± ± ±6.21 p* *Mann-Whitney U-test. M, male; F, female. (27 undergoing monotherapy and 21 undergoing monotherapy) and 42 healthy controls. The demographic and clinical features of the patients and the control participants are shown in Table 1. There were no statistically significant differences among patient and control groups in terms of mean age or sex (p<0.05; Table 1). The levels of calcium, ionized calcium, and 25-OH vitamin-d3 did not differ significantly between males and females in either the patient or control group (p>0.05; Table 2). The levels of calcium and ionized calcium were normal in patients using, but they were lower than those of the control group (p<0.01). The levels of calcium and ionized calcium did not differ significantly between patients using or and members of the control group (p>0.05). However, the 25-OH vitamin-d3 levels of both patient groups were lower than that of the control group (Table 3). Among the patients using, there were no significant differences between the duration of drug usage, daily drug dosage, or ionized calcium or 25-OH vitamin-d3 levels (p>0.05). Among the patients using, there were no significant differences between daily drug dosage or calcium or 25-OH vitamin-d3 levels (p>0.05; Table 4). However, there was a significant negative correlation between daily drug dosage and ionized calcium levels (r, 0.494; p<0.05; Table 5).
3 76 D. Aksoy, et al. Table 3. Calcium, ionized calcium, and 25-OH vitamin-d3 levels Oxcarbazepine Levetiracetam Control group (n=42) p value Calcium ( mg/dl)** 8.94± ± ± * Ionized calcium ( mg/dl)** 4.25± ± ± * 25-OH vitamin-d3 (20-80 ng/ml)** 7.29± ± ± * *p<0.05, **normal levels. Table 4. Calcium, ionized calcium, and 25-OH vitamin-d3 levels and duration of drug usage Table 5. Calcium, ionized calcium, and 25-OH vitamin-d3 levels and age and total drug dose Duration of drug usage and calcium r p Duration of drug usage and ionized calcium Duration of drug usage and 25-OH vitamin-d3, oxcarbazepine;, levetiracetam. r, Spearman s correlation coefficient. r p r p Total dose and calcium r p Total dose and ionized calcium r p * Total dose and 25-OH vitamin-d3 r p , oxcarbazepine;, levetiracetam. r, Spearman s correlation coefficient; *p<0.05. DISCUSSION Because the risk of fractures in patients with epilepsy is two- to sixfold higher than that in the general population, it is thought that AEDs may negatively affect bone metabolism. 10) However, the adverse effects that AEDs exert on bone mineral metabolism have yet to be fully clarified. It has been suggested that these drugs affect the metabolism of 25-OH vitamin-d3 which, in turn, leads to reduced calcium absorption. The subsequent reduction in calcium levels could cause secondary parathyrotoxicosis that would negatively affect bone metabolism. On the other hand, the findings of several other studies suggest otherwise ) Only a few studies have investigated the relationship between new-generation AEDs and bone mineral metabolism. One of the important findings from the present study was that 25-OH vitamin-d3 levels were low in both the patient and the control groups. It is known that weather can influence 25-OH vitamin-d3 levels such that they are highest at the end of summer and lowest at the end of winter. The fact that the blood samples used in the present study were obtained from participants at the end of winter may explain the low levels of 25-OH vitamin-d3. However, because the blood samples were taken from the patient and control groups during the same period, the findings of the study should not have been influenced by this variable. An individual s style of dress may also affect 25-OH vitamin-d3 levels because clothes act as an important barrier between ultraviolet light and skin. For example, in Arabic countries, it is known that the traditional way of dressing prevents the benefits of exposure to sunlight and can cause a 25-OH vitamin-d3 deficiency even though there is an abundant amount of sunlight. 3) In the present study, the participants style of dress may have contributed to the low levels of 25-OH vitamin-d3 that were observed. Thus, the present finding that the control group exhibited a 25-OH vitamin-d3 deficiency demonstrates that appropriate exposure to sunlight is an important public health issue that must be taken seriously. In the present study, the calcium, ionized calcium, and 25-OH vitamin-d3 levels of the patients using were lower than those of the control group, which is compatible with previous findings. There were no correlations between daily usage and calcium, ionized calcium, and 25-OH vitamin-d3 levels, but decreased calcium levels were associated with a longer duration of usage; this trend was nearly statistically significant. It has been emphasized in the literature that an increased duration of drug usage lowers calcium levels ) Mintzer et al. 18) found that, depending on the dosage, patients using exhibit significantly lower 25-OH vitamin-d3 levels and suggested that there may be an inductive effect of on cytochrome P450 or that it may affect osteoblast proliferation. Verotti et al. 4) reviewed the literature related to the effects of classic and novel AEDs on bone health and concluded that the abnormalities in calcium metabolism associated with these drugs result from their ability to induce the activity of cytochrome P450, which, in turn, causes reductions in 25-OH vitamin-d3 levels. However, the effects of many medications cannot be readily explained by
4 Antiepileptic Drugs, Bone Health OH vitamin-d3 metabolism. 4) And, in fact, a number of other reports have produced conflicting evidence. 13,14,19) Based on these and the present findings, it is suggested that follow-up visits and 25-OH vitamin-d3 replacement therapy should be mandatory for patients that have been on treatment for a significant period of time because they may have low 25-OH vitamin-d3, calcium, and ionized calcium levels. Only a few studies have investigated the effects of on bone health, and the findings are controversial. Some of these studies found that has no effect on bone health and that it does not affect serum calcium and 25-OH vitamin-d3 levels. 20,21) The calcium, ionized calcium, and 25-OH vitamin-d3 levels of patients undergoing monotherapy in the present study did not significantly differ from those of the control group. The fact that is metabolized at a very low rate and that it does not have any influence on the cytochrome P450 enzyme system may be the reasons it does not negatively influence bone health. Additionally, there were no significant differences in the calcium, ionized calcium, and 25-OH vitamin-d3 levels of the present patients receiving treatment according to duration of treatment, and only their ionized calcium levels decreased as the dosage increased. In a recent study, Nissen-Meyer et al. 22) found that may change bone formation and quality without affecting bone mass and suggested that may have a specific negative influence on trabecular bone structure rather than cortical bone structure. Although these authors could not exclude the possibility that the changes in bone structure were due to -induced reductions in estrogen, they did not find any evidence of enhanced bone turnover related to estrogen deficiencies. In that rodent study, low-dose caused a selective reduction in the biomechanical strength of the femoral neck, which represents metabolically active trabecular bone and the site where patients have an increased risk of fractures, without affecting bone mass and also resulted in reduced osteocalcin levels relative to controls. Because high-dose did not impact bone parameters in that study, the authors suggested there may be a dose-dependent biphasic effect of on bone. 22,23) Although relatively scarce, other studies investigating have also shown that does not affect trabecular bone. 19) This discrepancy may be attributed to differences in bone growth and metabolism between rats and humans and the fact that the dosages used in the rat studies were much higher ( mg/kg) than the amounts used in human studies. 23) Thus, clinical epidemiological studies are necessary to clarify this issue in humans. In a retrospective study, Beniczky et al. 24) observed a reduction in the bone mineral density of patients undergoing treatment and suggested that these measurements should be considered for all adult patients receiving long-term or treatment. These findings suggest that increased dosages of, and possibly other AEDS, may have a negative influence on the health of the bone structure. Recent studies have indicated that annual measurements of 25-OH vitamin-d3 levels in patients using AEDs should be required and that this population may benefit from prophylactic 25-OH vitamin-d3 treatment. 25) However, there is a lack of treatment guidelines regarding this issue. In the present study, the mean calcium, ionized calcium, and 25-OH vitamin-d3 levels of patients undergoing monotherapy were lower than those of the control group, whereas the values of the patients receiving monotherapy were similar to those of the control group. These findings indicate that there is clinical value in regularly assessing the 25-OH vitamin-d3 levels of patients with epilepsy who are being treated with old- and new-generation AEDs and that this patient population may benefit from 25-OH vitamin-d3 and calcium supplementation. Furthermore, it may be necessary to more closely assess the 25-OH vitamin-d3 and calcium levels of female patients in the peri- and postmenopausal periods as well as those of elderly patients and patients with any metabolic bone disorder. Additionally, these patients must be reminded to be conscious of maintaining a regular diet, engaging in physical exercise, exposing their bare skin to sunlight, and avoiding the risk factors of osteopenia, such as tobacco and alcohol. REFERENCES 1. Hauser WA, Annegers JF, Rocca WA. Descriptive epidemiology of epilepsy: contributions of population-based studies from Rochester, Minnesota. Mayo Clin Proc 1996;71: Adams RD, Victor M, Ropper AH. Epilepsy and other seizure disorder. In: Adams RD, editor. Principles of neurology. 7th ed. New York:McGraw-Hill;2001. p Dawodu A, Kochiyil J, Altaye N. Pilot study of sunlight exposure and vitamin D status in Arab women of childbearing age. East Mediterr Health J 2011;17: Verrotti A, Coppola G, Parisi P, Mohn A, Chiarelli F. Bone and calcium metabolism and antiepileptic drugs. Clin Neurol Neurosurg 2010;112: Deckers CL, Genton P, Sills GJ, Schmidt D. Current limitations of antiepileptic drug therapy: a conference review. Epilepsy Res 2003;53: Elliott JO, Jacobson MP. Bone loss in epilepsy: barriers to prevention, diagnosis, and treatment. Epilepsy Behav 2006; 8:
5 78 D. Aksoy, et al. 7. Souverein PC, Webb DJ, Petri H, Weil J, Van Staa TP, Egberts T. Incidence of fractures among epilepsy patients: a population-based retrospective cohort study in the General Practice Research Database. Epilepsia 2005;46: Pack AM, Morrell MJ. Adverse effects of antiepileptic drugs on bone structure: epidemiology, mechanisms and therapeutic implications. CNS Drugs 2001;15: Pack AM, Morrell MJ. Epilepsy and bone health in adults. Epilepsy Behav 2004;5 Suppl 2:S24-S Souverein PC, Webb DJ, Weil JG, Van Staa TP, Egberts AC. Use of antiepileptic drugs and risk of fractures: case-control study among patients with epilepsy. Neurology 2006;66: Verrotti A, Greco R, Latini G, Morgese G, Chiarelli F. Increased bone turnover in prepubertal, pubertal, and postpubertal patients receiving carbamazepine. Epilepsia 2002;43: Svalheim S, Røste LS, Nakken KO, Taubøll E. Bone health in adults with epilepsy. Acta Neurol Scand Suppl 2011; (191): Miziak B, Błaszczyk B, Chrościńska-Krawczyk M, Danilkiewicz G, Jagiełło-Wójtowicz E, Czuczwar SJ. The problem of osteoporosis in epileptic patients taking antiepileptic drugs. Expert Opin Drug Saf 2014;13: Babacan O, Karaoglu A, Vurucu S, Yesilkaya E, Yesilyurt O, Cayci T, et al. May long term oxcarbazepine treatment be lead to secondary hyperparathyroidism? J Clin Neurol 2012;8: Cansu A, Yesilkaya E, Serdaroğlu A, Hirfanoğlu TL, Camurdan O, Gülbahar O, et al. Evaluation of bone turnover in epileptic children using oxcarbazepine. Pediatr Neurol 2008;39: Bauer S, Hofbauer LC, Rauner M, Strzelczyk A, Kellinghaus C, Hallmeyer-Elgner S, et al. Early detection of bone metabolism changes under different antiepileptic drugs (ED- BoM-AED)--a prospective multicenter study. Epilepsy Res 2013;106: Koo DL, Hwang KJ, Han SW, Kim JY, Joo EY, Shin WC, et al. Effect of oxcarbazepine on bone mineral density and biochemical markers of bone metabolism in patients with epilepsy. Epilepsy Res 2014;108: Mintzer S, Boppana P, Toguri J, DeSantis A. Vitamin D levels and bone turnover in epilepsy patients taking carbamazepine or oxcarbazepine. Epilepsia 2006;47: Cetinkaya Y, Kurtulmuş YS, Tutkavul K, Tireli H. The effect of oxcarbazepine on bone metabolism. Acta Neurol Scand 2009;120: Koo DL, Joo EY, Kim D, Hong SB. Effects of levetiracetam as a monotherapy on bone mineral density and biochemical markers of bone metabolism in patients with epilepsy. Epilepsy Res 2013;104: Lee R, Lyles K, Sloane R, Colón-Emeric C. The association of newer anticonvulsant medications and bone mineral density. Endocr Pract 2012;14: Nissen-Meyer LS, Svalheim S, Taubøll E, Reppe S, Lekva T, Solberg LB, et al. Levetiracetam, phenytoin, and valproate act differently on rat bone mass, structure, and metabolism. Epilepsia 2007;48: Nissen-Meyer LS, Svalheim S, Taubøll E, Gjerstad L, Reinholt FP, Jemtland R. How can antiepileptic drugs affect bone mass, structure and metabolism? Lessons from animal studies. Seizure 2008;17: Beniczky SA, Viken J, Jensen LT, Andersen NB. Bone mineral density in adult patients treated with various antiepileptic drugs. Seizure 2012;21: Drezner MK. Treatment of anticonvulsant drug-induced bone disease. Epilepsy Behav 2004;5 Suppl 2:S41-S47.
Levetiracetam monotherapy effect on serum calcium and serum vitamin D in patient of epilepsy
International Journal of Research in Medical Sciences Garg A et al. Int J Res Med Sci. 2017 Feb;5(2):503-508 www.msjonline.org pissn 2320-6071 eissn 2320-6012 Original Research Article DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20170140
More informationOriginal Research Article
Submitted on: February 2015 Accepted on: February 2015 For Correspondence Email ID: Medrech ISSN No. 2394-3971 Original Research Article EFFECTS OF LEVETIRACETAM AND TOPIRAMATE ON BONE HEALTH IN ADULTS,
More informationHow can antiepileptic drugs affect bone mass, structure and metabolism? Lessons from animal studies
Seizure (2008) 17, 187 191 www.elsevier.com/locate/yseiz REVIEW How can antiepileptic drugs affect bone mass, structure and metabolism? Lessons from animal studies Lise Sofie H. Nissen-Meyer a,1, Sigrid
More informationEastern Paediatric Epilepsy Network
1. Objective 2. Background 3. Vitamin D and epilepsy 4. Monitoring and optimizing bone health in healthy children 5. 6. Recommendations 1.) Objective: 1.1) To provide a rational basis for monitoring bone
More informationA Study on the Relationship between CBC and EEG for Epilepsy Patients
ORIGINAL ARTICLE Korean J Clin Lab Sci. 2015, 47(4):225-229 http://dx.doi.org/10.15324/kjcls.2015.47.4.225 pissn 1738-3544 eissn 2288-1662 Korean J Clin Lab Sci. Vol. 47, No. 4, Dec. 2015 225 A Study on
More informationOnset of epilepsy and menarche Is there any relationship?
Seizure (2006) 15, 571 575 www.elsevier.com/locate/yseiz Onset of epilepsy and menarche Is there any relationship? Sigrid Svalheim a, *, Erik Taubøll a,b, Tone Bjørnenak a, Line S. Røste a, Tore Mørland
More information11b). Does the use of folic acid preconceptually decrease the risk of foetal malformations in women with epilepsy?
updated 2012 Management of epilepsy in women of child bearing age Q11: 11a). In women with epilepsy, should antiepileptic therapy be prescribed as monotherapy or polytherapy to decrease the risk of fetal
More informationEpilepsy and EEG in Clinical Practice
Mayo School of Professional Development Epilepsy and EEG in Clinical Practice November 10-12, 2016 Hard Rock Hotel at Universal Orlando Orlando, FL Course Directors Jeffrey Britton, MD and William Tatum,
More informationSomnolence and Sedation Were Transient Adverse Events for Most Patients Receiving Clobazam Therapy: Post Hoc Analysis of Trial OV-1012 Data
Elmer ress Short Communication J Neurol Res. 2015;5(4-5):252-256 Somnolence and Sedation Were Transient Adverse Events for Most Patients Receiving Clobazam Therapy: Post Hoc Analysis of Trial OV-1012 Data
More informationLong-Term Efficacy and Safety of Zonisamide Monotherapy in Epilepsy Patients
Journal of Clinical Neurology / Volume 3 / December, 2007 Original Articles Long-Term Efficacy and Safety of Zonisamide Monotherapy in Epilepsy Patients Sung-Pa Park, M.D., Sun-Young Kim, M.D., Yang-Ha
More informationEffect Of Anticonvulsant Drugs On Lipid Profile In Epileptic Patients
ISPUB.COM The Internet Journal of Neurology Volume 3 Number 1 Effect Of Anticonvulsant Drugs On Lipid Profile In Epileptic Patients P Kumar, M Tyagi, Y Tyagi, A Kumar, A Kumar, Y Rai Citation P Kumar,
More informationEpilepsy is a very individualized
... PRESENTATION... Treatment of Epilepsy in 3 Specialized Populations Based on a presentation by Ilo E. Leppik, MD Presentation Summary When discussing the treatment of epilepsy, targeted populations
More informationCHILDHOOD OCCIPITAL EPILEPSY OF GASTAUT: A LONG-TERM PROSPECTIVE STUDY
Acta Medica Mediterranea, 2017, 33: 1175 CHILDHOOD OCCIPITAL EPILEPSY OF GASTAUT: A LONG-TERM PROSPECTIVE STUDY MURAT GÖNEN ¹, EMRAH AYTAǹ, BÜLENT MÜNGEN¹ University of Fırat, Faculty of medicine, Neurology
More informationCorrelation between Thyroid Function and Bone Mineral Density in Elderly People
IBBJ Spring 2016, Vol 2, No 2 Original Article Correlation between Thyroid Function and Bone Mineral Density in Elderly People Ali Mirzapour 1, Fatemeh Shahnavazi 2, Ahmad Karkhah 3, Seyed Reza Hosseini
More informationJOURNAL OF INTERNATIONAL ACADEMIC RESEARCH FOR MULTIDISCIPLINARY Impact Factor 1.393, ISSN: , Volume 2, Issue 7, August 2014
HYPOVITAMINOSIS D IN INDIAN FEMALES WITH POSTMENOPAUSAL OSTEOPOROSIS DR. SHAH WALIULLAH 1 DR. VINEET SHARMA 2 DR. R N SRIVASTAVA 3 DR. YASHODHARA PRADEEP 4 DR. A A MAHDI 5 DR. SANTOSH KUMAR 6 1 Research
More informationPART VI: SUMMARY OF THE RISK MANAGEMENT PLAN 2 RISKS ASSOCIATED WITH THE MEDICINE AND ACTIVITIES TO MINIMIZE OR FURTHER CHARACTERISE THE RISKS
PART VI: SUMMARY OF THE RISK MANAGEMENT PLAN Summary of risk management plan for Briviact This is a summary of the risk management plan (RMP) for Briviact. The RMP details important risks of Briviact,
More informationDifficult to treat childhood epilepsy: Lessons from clinical case scenario
Difficult to treat childhood epilepsy: Lessons from clinical case scenario Surachai Likasitwattanakul, M.D. Department of Pediatrics Faculty of Medicine, Siriraj Hospital Natural history of Epilepsy Untreated
More informationMedications for Epilepsy What I Need to Know
Medications for Epilepsy What I Need to Know Safiya Ladak, BSc.Phm. Toronto Western Hospital, UHN Clinical Pharmacist, Neurology and Neurosurgery June 4, 2016 Learning Objectives Treatment options for
More informationRESEARCH ARTICLE. Mohammad Reza SALEHIOMRAN MD 1, Seyyed Esmaeil HOSSEINI KORDKHEILY MD 2
RESEARCH ARTICLE THE EFFECT OF ANTICONVULSANT DRUGS (PHENOBARBITAL AND VALPROIC ACID) ON THE SERUM LEVEL OF CHOLESTEROL, TRIGLYCERIDE, LIPOPROTEIN AND LIVER ENZYMES IN CONVULSIVE CHILDREN Mohammad Reza
More informationIDENTIFYING TARGET POPULATIONS & DESIGNING CLINICAL TRIALS FOR ANTIEPILEPTOGENESIS. Ettore Beghi Istituto Mario Negri, Milano ITALY
IDENTIFYING TARGET POPULATIONS & DESIGNING CLINICAL TRIALS FOR ANTIEPILEPTOGENESIS Ettore Beghi Istituto Mario Negri, Milano ITALY OUTLINE Definitions & background risks in epilepsy End-points Target populations
More informationTRANSPARENCY COMMITTEE OPINION. 19 July 2006
The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 19 July 2006 Keppra 250 mg, film-coated tablets Box of 60 tablets (CIP code: 356 013-6) Keppra 500 mg, film-coated
More informationA Case of Cushing Syndrome Diagnosed by Recurrent Pathologic Fractures in a Young Woman
A Case of Cushing Syndrome Diagnosed by Recurrent Pathologic Fractures in a Young Woman JY Han, et al CASE REPORT http://dx.doi.org/10.11005/jbm.2012.19.2.153 Vol. 19, No. 2, 2012 A Case of Cushing Syndrome
More informationWhen choosing an antiepileptic ... PRESENTATION... Pharmacokinetics of the New Antiepileptic Drugs. Based on a presentation by Barry E.
... PRESENTATION... Pharmacokinetics of the New Antiepileptic Drugs Based on a presentation by Barry E. Gidal, PharmD Presentation Summary A physician s choice of an antiepileptic drug (AED) usually depends
More informationAlthough the prevalence of epilepsy and
NEW-ONSET EPILEPSY IN WOMEN: AN INDICATION FOR A NEWER ANTIEPILEPTIC DRUG? Jeffrey Cohen, MD, PhD* ABSTRACT Seizure patterns are often related to the reproductive cycles of a woman with epilepsy. Seizures
More informationOsteoporosis is associated with antiepileptic drugs: a population-based study
Original article Epileptic Disord 2014; 16 (3): 333-42 Osteoporosis is associated with antiepileptic drugs: a population-based study Fang-Jen Wu 1, Shiow-Yunn Sheu 1, Herng-Ching Lin 2 1 School of Pharmacy
More informationAntiepileptic drugs and cardiovascular disease June 21, 2012
Antiepileptic drugs and cardiovascular disease June 21, 2012 Scott Mintzer, MD Associate Professor of Neurology Jefferson Comprehensive Epilepsy Center Thomas Jefferson University Philadelphia, PA Partners
More informationBone Metabolism in Postmenopausal Women Influenced by the Metabolic Syndrome
Bone Metabolism in Postmenopausal Women Influenced by the Metabolic Syndrome Thomas et al. Nutrition Journal (2015) 14:99 DOI 10.1186/s12937-015-0092-2 RESEARCH Open Access Acute effect of a supplemented
More informationOccurrence and Risk Factors for Post-traumatic Epilepsy in Civilian Poulations December 2, 2012
Occurrence and Risk Factors for Post-traumatic Epilepsy in Civilian Poulations December 2, 2012 Dale C Hesdorffer, PhD GH Sergievsky Center Columbia University American Epilepsy Society Annual Meeting
More informationDisclosures. Objectives 2/16/2015. Women with Epilepsy: Seizures in Pregnancy and Maternal/Fetal Outcomes
Women with Epilepsy: Seizures in Pregnancy and Maternal/Fetal Outcomes 40 th Annual Progress in OBGYN February 19, 2015 Jennifer L. DeWolfe, DO Associate Professor UAB Epilepsy Center Director, BVAMC Sleep
More informationOriginal Article. Bone Density of Ambulatory Adult Patients Receiving Long-term Anticonvulsant Drug Therapy
Arch Iran Med 2009; 12 (6): 550 554 Original Article Bone Density of Ambulatory Adult Patients Receiving Long-term Anticonvulsant Drug Therapy Nahid Ashjazadeh MD*, Ali Zamani MD**, ***, Mehrzad Pourjafar
More informationE. Viteva Department of Neurology, Medical University of Plovdiv
IMPORTANCE OF SOME CLINICAL FACTORS (EPILEPSY DURATION, CLUSTERS OF SEIZURES AND/OR EPILEPTIC STATUS, TYPE OF EPILEPSY, TYPE OF SEIZURES, MONO-/ POLYTHERAPY) FOR THE QUALITY OF LIFE OF PATIENTS WITH REFRACTORY
More information4.7 Studies of Quality Holy Cross Hospital Bone Health Early Stage I ER/PR Positive Breast Cancer Patients December 13, 2017
4.7 Studies of Quality Holy Cross Hospital 2017 Bone Health Early Stage I ER/PR Positive Breast Cancer Patients December 13, 2017 Bone Health in Stage I ER/PR Positive Breast Cancer Patients To review
More informationSex Hormones, Sexuality and Fertility: Effects of Epilepsy and its Treatments. Associate Professor Beverley Vollenhoven
Sex Hormones, Sexuality and Fertility: Effects of Epilepsy and its Treatments Associate Professor Beverley Vollenhoven Reproductive Endocrinologist and Infertility Specialist Head of Gynaecology Southern
More informationPrevalence Of Vitamin D Inadequacy In Peri And Postmenopausal Women Presented At Dow University Hospital, Ojha Campus. A Cross Sectional Study
ISPUB.COM The Internet Journal of Nutrition and Wellness Volume 12 Number 1 Prevalence Of Vitamin D Inadequacy In Peri And Postmenopausal Women Presented At Dow University S Shukar-ud-din, R Tabassum,
More informationA FRAX Experience in Korea: Fracture Risk Probabilities with a Country-specific Versus a Surrogate Model
J Bone Metab 15;:113-11 http://dx.doi.org/.15/jbm.15..3.113 pissn 7-375 eissn 7-79 Original Article A FRAX Experience in Korea: Fracture Risk Probabilities with a Country-specific Versus a Surrogate Model
More informationThe Clinical Effects of Carthami-Flos Pharmacopuncture on Posterior Neck pain of Menopausal Women
ISSN 2093-6966 Journal of Pharmacopuncture 71 http://dx.doi.org/10.3831/kpi.2011.14.4.071 Received : Nov 10, 2011 Revised : Nov 25, 2011 Accepted : Nov 30, 2011 KEY WORDS: Carthami-Flos; Neck pain, Pharmacopuncture;
More informationINTRODUCTION. Original Article
J Bone Metab 2015;22:135-141 http://dx.doi.org/10.11005/jbm.2015.22.3.135 pissn 2287-6375 eissn 2287-7029 Original Article Change of Bone Mineral Density and Biochemical Markers of Bone Turnover in Patients
More informationThe Effectiveness of Monotheraby in Epileptic Sudanese Patients
The Effectiveness of Monotheraby in Epileptic Sudanese Patients Amel Elmahi Mohamed (1) Sawsan A Aldeaf (1) Alsadig Gassoum (1) Alnada Abdalla Mohamed (2) Mohamed A Arbab (1,3) and Alamin Ebrahim (2) Abstract
More informationEffects of Antiepileptic Drugs on Bone Density and Metabolism
DOI: 10.14744/epilepsi.2016.93723 REVIEW / DERLEME Effects of Antiepileptic Drugs on Bone Density and Metabolism Antiepileptik İlaçların Kemik Yoğunluğuna ve Metabolizmasına Etkileri Zeynep AYDIN ÖZEMİR,
More informationDuring the past decade, several new
ASSESSING AND PREVENTING THE METABOLIC SIDE EFFECTS OF ANTIEPILEPTIC DRUGS Barry E. Gidal, PharmD, BCPS, RPh* ABSTRACT The introduction of the newer antiepileptic drugs (AEDs) has increased the number
More informationThe Risk of Fracture with Taking Alpha Blockers for Treating Benign Prostatic Hyperplasia
J Prev Med Public Health 2009;42(3):165-170 DOI: 103961/jpmph2009423165 The Risk of Fracture with Taking Alpha Blockers for Treating Benign Prostatic Hyperplasia Joongyub Lee 1) Nam-Kyoung Choi 13) Sun-Young
More informationEpilepsy: problems of diagnosis and recommended treatment Nicola Cooper MRCP and Morgan Feely MD, FRCP, FRCP(I)
Epilepsy: problems of diagnosis and recommended treatment Nicola Cooper MRCP and Morgan Feely MD, FRCP, FRCP(I) VM Our series Prescribing in gives practical advice for successful management of the special
More informationEfficacy of Levetiracetam: A Review of Three Pivotal Clinical Trials
Epilepsia, 42(Suppl. 4):31 35, 2001 Blackwell Science, Inc. International League Against Epilepsy Efficacy of : A Review of Three Pivotal Clinical Trials Michael Privitera University of Cincinnati Medical
More informationA study of serum level of trace elements in patients with childhood epilepsy
International Journal of Contemporary Pediatrics Singh A et al. Int J Contemp Pediatr. 2016 Nov;3(4):xxx-xxx http://www.ijpediatrics.com pissn 2349-3283 eissn 2349-3291 Research Article DOI: http://dx.doi.org/10.18203/2349-3291.ijcp20162803
More informationRelation between the Peripherofacial Psoriasis and Scalp Psoriasis
pissn 1013-9087ㆍeISSN 2005-3894 Ann Dermatol Vol. 28, No. 4, 2016 http://dx.doi.org/10.5021/ad.2016.28.4.422 ORIGINAL ARTICLE Relation between the Peripherofacial Psoriasis and Scalp Psoriasis Kyung Ho
More informationSpecial Considerations for Managing Women With Epilepsy
1 Special Considerations for Managing Women With Epilepsy Brought to you by Upsher-Smith with contributions from Cynthia L. Harden, MD In recent years, there has been an increased focus on genderrelated
More informationRefractory epilepsy: treatment with new antiepileptic drugs
Seizure 2000; 9: 51 57 doi: 10.1053/seiz.1999.0348, available online at http://www.idealibrary.com on Refractory epilepsy: treatment with new antiepileptic drugs P. K. DATTA & P. M. CRAWFORD Department
More informationThe Bare Bones of Osteoporosis. Wendy Rosenthal, PharmD
The Bare Bones of Osteoporosis Wendy Rosenthal, PharmD Definition A systemic skeletal disease characterized by low bone mass and microarchitectural deterioration of bone tissue, with a consequent increase
More informationThe Diabetes Epidemic in Korea
Review Article Endocrinol Metab 2016;31:349-33 http://dx.doi.org/.3803/enm.2016.31.3.349 pissn 2093-96X eissn 2093-978 The Diabetes Epidemic in Korea Junghyun Noh Department of Internal Medicine, Inje
More informationWomen s Issues in Epilepsy. Esther Bui, Epilepsy Fellow MD, FRCPC
Women s Issues in Epilepsy Esther Bui, Epilepsy Fellow MD, FRCPC How are women different? Different habitus Different metabolism Different co-morbidities Different psychosocial stigma Different hormonal
More informationORIGINAL CONTRIBUTION. patients. According to
Hospital-Onset Seizures An Inpatient Study ORIGINAL CONTRIBUTION Madeline C. Fields, MD; Daniel L. Labovitz, MD; Jacqueline A. French, MD Objectives: To describe demographic and clinical characteristics
More informationSeizures in high-grade glioma patients:
Seizures in high-grade glioma patients: a serious challenge in the end of life phase JAF Koekkoek,* EM Sizoo,* TJ Postma, JJ Heimans, HRW Pasman, L Deliens, MJB Taphoorn and JC Reijneveld BMJ Support Palliat
More informationEvaluation of bone health among epileptic patients using biochemical markers and DEXA scan: an Egyptian study
Fahmy et al. The Egyptian Journal of Neurology, Psychiatry and Neurosurgery (2018) 54:10 https://doi.org/10.1186/s41983-018-0014-2 The Egyptian Journal of Neurology, Psychiatry and Neurosurgery RESEARCH
More informationThe Epilepsy Prescriber s Guide to Antiepileptic Drugs
The Epilepsy Prescriber s Guide to Antiepileptic Drugs The Epilepsy Prescriber s Guide to Antiepileptic Drugs Philip N. Patsalos FRCPath, PhD Professor of Clinical Pharmacology and Consultant Clinical
More informationRelationship between Bone Density, Eating Habit, and Nutritional Intake in College Students
J Bone Metab 2018;25(3):181-186 https://doi.org/10.11005/jbm.2018.25.3.181 pissn 2287-6375 eissn 2287-7029 Original Article Relationship between Bone Density, Eating Habit, and Nutritional Intake in College
More informationVitamin D status among children and adolescents on anticonvulsant drugs in Southern Switzerland
Published 13 August 2014, doi:10.4414/smw.2014.13996 Cite this as: Vitamin D status among children and adolescents on anticonvulsant drugs in Southern Switzerland Vera Ramelli a, Gian Paolo Ramelli a,
More informationZeenat Ali, PGY3 Joseph Grisanti, MD June 7 th, 2012
A Randomized Open Label Trial to Evaluate the Efficacy of Different Dosage Forms of Vitamin D in Patients with Vitamin D Deficiency, and the Effect of Food on Vitamin D Absorption. Zeenat Ali, PGY3 Joseph
More informationAn open-label pilot study on the efficacy and tolerability of levetiracetam in the prophylaxis of migraine
J Headache Pain () :9 9 DOI 1.1/s119--- RAPID COMMUNICATION Virgilio Gallai Andrea Alberti Cristiana Rossi Francesca Coppola Beatrice Gallai Giovanni Mazzotta Paola Sarchielli An open-label pilot study
More informationVITAMIN D AND THE ATHLETE
VITAMIN D AND THE ATHLETE CONSIDERATIONS FOR THE PRACTITIONER Written by Bruce Hamilton, Qatar Vitamin D is a steroid hormone that has previously been given little attention, partially as a result of its
More informationNew Medicines Profile
New Medicines Profile February 2010 Issue No. 10/02 Eslicarbazepine Concise evaluated information to support the managed entry of new medicines in the NHS Brand Name, (Manufacturer): Zebinix (Eisai Limited)
More informationInt.J.Curr.Res.Aca.Rev.2016; 4(7): 32-37
Evaluation of Clinical Outcome, Drug Utilization and Effect on Liver Enzymes of Anti-epileptics in Epileptic Patients Mathew George 1, Lincy Joseph 2, Robert Mathew 3 and Preethi Christina Jose 4 * 1 Department
More information2018 American Academy of Neurology
Practice Guideline Update Efficacy and Tolerability of the New Antiepileptic Drugs I: Treatment of New-Onset Epilepsy Report by: Guideline Development, Dissemination, and Implementation Subcommittee of
More informationKeywords: treatment; epilepsy; population based cohort Institute of Neurology, University College London, London WC1N 3BG, UK
632 Institute of Neurology, University College London, London WC1N 3BG, UK S D Lhatoo JWASSander S D Shorvon Correspondence to: Professor J W Sander, Department of Clinical and Experimental Epilepsy, Institute
More informationTherapeutic strategies in the choice of antiepileptic drugs
Acta neurol. belg., 2002, 102, 6-10 Original articles Therapeutic strategies in the choice of antiepileptic drugs V. DE BORCHGRAVE, V. DELVAUX, M. DE TOURCHANINOFF, J.M. DUBRU, S. GHARIANI, Th. GRISAR,
More informationIEHP UM Subcommittee Approved Authorization Guidelines DEXA Scan
Policy: IEHP UM Subcommittee Approved Authorization Guidelines IEHP considers bone mineral density testing using DEXA medically necessary for members who meet any of the following criteria: Women aged
More informationCa, Mg metabolism, bone diseases. Tamás Kőszegi Pécs University, Department of Laboratory Medicine Pécs, Hungary
Ca, Mg metabolism, bone diseases Tamás Kőszegi Pécs University, Department of Laboratory Medicine Pécs, Hungary Calcium homeostasis Ca 1000g in adults 99% in bones (extracellular with Mg, P) Plasma/intracellular
More informationThe New England Journal of Medicine A POPULATION-BASED STUDY OF SEIZURES AFTER TRAUMATIC BRAIN INJURIES
A POPULATION-BASED STUDY OF SEIZURES AFTER TRAUMATIC BRAIN INJURIES JOHN F. ANNEGERS, PH.D., W. ALLEN HAUSER, M.D., SHARON P. COAN, M.S., AND WALTER A. ROCCA, M.D., M.P.H. ABSTRACT Background The risk
More informationManagement of postmenopausal osteoporosis
Management of postmenopausal osteoporosis Yeap SS, Hew FL, Chan SP, on behalf of the Malaysian Osteoporosis Society Committee Working Group for the Clinical Guidance on the Management of Osteoporosis,
More informationEffects of Antiepileptic Drug Substitutions on Epileptic Events Requiring Acute Care
Effects of Antiepileptic Drug Substitutions on Epileptic Events Requiring Acute Care Karen L. Rascati, Ph.D., Kristin M. Richards, Ph.D., Michael T. Johnsrud, Ph.D., and Teresa A. Mann, Pharm.D. Study
More information2011 MNA Midwest Summer Conference
2011 MNA Midwest Summer Conference Women and Epilepsy Marianna V. Spanaki, M.D., Ph.D., M.B.A. SENIOR STAFF NEUROLOGIST DIRECTOR EPILEPSY MONITORING UNIT HENRY FORD COMPREHENSIVE EPILEPSY PROGRAM HENRY
More informationNational Utilization of Calcium Supplements in Patients with Osteoporotic Hip Fracture in Korea
J Bone Metab 2013;20:99-103 http://dx.doi.org/10.11005/jbm.2013.20.2.99 pissn 2287-6375 eissn 2287-7029 Original Article National Utilization of Calcium Supplements in Patients with Osteoporotic Hip Fracture
More informationReview of Anticonvulsant Medications: Traditional and Alternative Uses. Andrea Michel, PharmD, CACP
Review of Anticonvulsant Medications: Traditional and Alternative Uses Andrea Michel, PharmD, CACP Objectives Review epidemiology of epilepsy Classify types of seizures Discuss non-pharmacologic and pharmacologic
More informationScottish Medicines Consortium
Scottish Medicines Consortium levetiracetam, 250, 500, 750 and 1000mg tablets and levetiracetam oral solution 100mg/ml (Keppra ) No. (394/07) UCB Pharma Limited 10 August 2007 The Scottish Medicines Consortium
More informationBasic Steps in Planning Research. Dr. P.J. Brink and Dr. M.J. Wood
Basic Steps in Planning Research Dr. P.J. Brink and Dr. M.J. Wood Research Levels Level 1: There is little or no literature available on the topic or on the population. The purpose is to describe what
More informationEpilepsy Patients in Saudi Arabia, Are They Eligible to Drive?
Epilepsy Patients in Saudi Arabia, Are They Eligible to Drive? 1 Wasaif I. Aljohani, 2 Bashayer F. Alsohime, 3 Maryam A. Nawwab, 4 Abdullah A. Alshehri, 5 Najd I. Aljuhani, 6 Rahaf T. Dashash, 7 Saggaff
More informationOsteoporosis. Overview
v2 Osteoporosis Overview Osteoporosis is defined as compromised bone strength that increases risk of fracture (NIH Consensus Conference, 2000). Bone strength is characterized by bone mineral density (BMD)
More informationDownloaded from jssu.ssu.ac.ir at 0:37 IRST on Sunday February 17th 2019
-2384 2 *. : 4 :. 2 / 4 3 6/. ( /) : 6 /4. 6. 00 92 6. 0 :. :. 0 :. International league Against Epilepsy (ILAE) First Unprovoked Seizure (FUS) 24 () (2) 20.. 2 3-4. (). : -* - 0 626024: 0 626024 : E-mial:
More informationCalcium Nephrolithiasis and Bone Health. Noah S. Schenkman, MD
Calcium Nephrolithiasis and Bone Health Noah S. Schenkman, MD Associate Professor of Urology and Residency Program Director, University of Virginia Health System; Charlottesville, Virginia Objectives:
More informationStudy of the Association between Serum Vitamin D 25(OH) D levels, Muscle Strength and fall among Elderly.
DOI: 10.21276/aimdr.2017.3.2.ME7 Original Article ISSN (O):2395-2822; ISSN (P):2395-2814 Study of the Association between Serum Vitamin D 25(OH) D levels, Muscle Strength and fall among Elderly. Karthik
More information18 y.o. female with amenorrhea. Olesya Krivospitskaya, MD Endorama 08/08/2013
18 y.o. female with amenorrhea Olesya Krivospitskaya, MD Endorama 08/08/2013 History of past illness: 18 y.o. female presented for the evaluation of a secondary amenorrhea Menarche at 12 Irregular menstrual
More informationPhenytoin, Levetiracetam, and Pregabalin in the Acute Management of Refractory Status Epilepticus in Patients with Brain Tumors
Neurocrit Care (2012) 16:109 113 DOI 10.1007/s12028-011-9626-4 ORIGINAL ARTICLE Phenytoin, Levetiracetam, and Pregabalin in the Acute Management of Refractory Status Epilepticus in Patients with Brain
More informationChapter 31-Epilepsy 1. public accountant, and has begun treatment with lamotrigine. In which of the following activities
Chapter 31-Epilepsy 1 Chapter 31. Epilepsy, Self-Assessment Questions 1. BW is a 28-year-old man recently diagnosed with partial seizures. He works as a certified public accountant, and has begun treatment
More informationlevetiracetam 250,500,750 and 1000mg tablets and levetiracetam oral solution 100mg/1ml (Keppra ) (No. 397/07) UCB Pharma Ltd
Scottish Medicines Consortium Resubmission levetiracetam 250,500,750 and 1000mg tablets and levetiracetam oral solution 100mg/1ml (Keppra ) (No. 397/07) UCB Pharma Ltd 11 January 2008 The Scottish Medicines
More informationBone and Mineral. Comprehensive Menu for the Management of Bone and Mineral Related Diseases
Bone and Mineral Comprehensive Menu for the Management of Bone and Mineral Related Diseases Innovation to Assist in Clinical Diagnosis and Treatment DiaSorin offers a specialty line of Bone and Mineral
More informationBackground. Correlation between epilepsy and attention deficit hyperactivity disorder. Background. Epidemiology of ADHD among children with epilepsy
Correlation between epilepsy and attention deficit hyperactivity disorder I-Ching Chou M.D. Director, Department of Pediatric Neurology China Medical University Hospital Taiwan Background Attention deficit/hyperactivity
More informationBAD TO THE BONE. Peter Jones, Rheumatologist QE Health, Rotorua. GP CME Conference Rotorua, June 2008
BAD TO THE BONE Peter Jones, Rheumatologist QE Health, Rotorua GP CME Conference Rotorua, June 2008 Agenda Osteoporosis in Men Vitamin D and Calcium Long-term treatment with Bisphosphonates Pathophysiology
More informationEpilepsy & Pregnancy READ ONLINE
Epilepsy & Pregnancy READ ONLINE Women with epilepsy have special concerns about conception and pregnancy - medication, dosing schedules, seizure management, delivery complications. Written by mums with
More informationRisk of seizure recurrence after antiepileptic drug withdrawal, an Indian study
Neurology Asia 2006; 11 : 19 23 Risk of seizure recurrence after antiepileptic drug withdrawal, an Indian study Archana VERMA DM (Neurology) MD, Surendra MISRA DM (Neurology) FRCP (Edin) Department of
More informationThe risk of epilepsy following
~~ Article abstract41 cohort of 666 children who had convulsions with fever were followed to determine the risks of subsequent epilepsy High risks were found in children with preexisting cerebral palsy
More informationUpdated advice for nurses who care for patients with epilepsy
NICE BULLETIN Updated advice for nurses who care for patients with epilepsy NICE provided the content for this booklet which is independent of any company or product advertised NICE BULLETIN Updated advice
More informationElecsys bone marker panel. Optimal patient management starts in the laboratory
bone marker panel Optimal patient management starts in the laboratory Complete solution for osteoporosis The most complete bone metabolism panel on a single platform bone marker assays are important diagnostic
More informationEPILEPSY PART II TREATMENT HANDBOOK OF CLINICAL NEUROLOGY
page 1 / 5 page 2 / 5 epilepsy part ii treatment pdf The Epilepsy Foundation is your unwavering ally on your journey with epilepsy and seizures. The Foundation is a communitybased, family-led organization
More informationRohit R. Das, 1 David A. Griesemer, 2 and Sanjeev V. Kothare Introduction. 2. Methods
ISRN Neurology Volume 2013, Article ID 613456, 4 pages http://dx.doi.org/10.1155/2013/613456 Research Article The Role of Phenytoin in the Treatment of Localization Related Epilepsy: An International Internet-Based
More informationManagement of Epilepsy in Primary Care and the Community. Carrie Burke, Epilepsy Specialist Nurse
Management of Epilepsy in Primary Care and the Community Carrie Burke, Epilepsy Specialist Nurse Epilepsy & Seizures Epilepsy is a common neurological disorder characterised by recurring seizures (NICE,
More informationStudy of secondary causes of male osteoporosis
Study of secondary causes of male osteoporosis Suárez, S.M., Giunta J., Meneses G., Costanzo P.R., Knoblovits P. Department of Endocrinology, Metabolism and Nuclear Medicine of Hospital Italiano of Buenos
More informationZinc Intake and Biochemical Markers of Bone Turnover in Type 1 Diabetes
Diabetes Care Publish Ahead of Print, published online September 22, 2008 Zinc and bone markers Zinc Intake and Biochemical Markers of Bone Turnover in Type 1 Diabetes Raelene E. Maser, PhD 1,2; John N.
More information9/16/2018. Recognizing & Managing Seizures in Pediatric TBI. Objectives. Definitions and Epidemiology
Recognizing & Managing Seizures in Pediatric TBI UW Medicine EMS & Trauma 2018 Conference September 17 and 18, 2018 Mark Wainwright MD PhD Herman and Faye Sarkowsky Professor of Neurology Division Head,
More informationOsteoporosis Treatment Overview. Colton Larson RFUMS October 26, 2018
Osteoporosis Treatment Overview Colton Larson RFUMS October 26, 2018 Burden of Disease Most common bone disease 9.9 million Americans + 43.1 million Americans have low bone mineral density (BMD) Stealthy
More informationStaging of Seizures According to Current Classification Systems December 10, 2013
Staging of Seizures According to Current Classification Systems December 10, 2013 Elinor Ben-Menachem, M.D.,Ph.D, Instituet of Clinical Neuroscience and Physiology, Sahlgren Academy, Goteborg University,
More informationA Study of relationship between frailty and physical performance in elderly women
Original Article Journal of Exercise Rehabilitation 2015;11(4):215-219 A Study of relationship between frailty and physical performance in elderly women Bog Ja Jeoung 1, *, Yang Chool Lee 2 1 Department
More information